Evidence-based electroconvulsive therapy

Acta Psychiatrica Scandinavica

Volumn 125, Issue 3, 2012, Pages 177-184

  Ottosson, Jan Otto ^a   Odeberg, Håkan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUMAZENIL; IMIPRAMINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; TRYPTOPHAN; VENLAFAXINE;

ANESTHESIA; ANTEROGRADE AMNESIA; ANTIDEPRESSANT ACTIVITY; CATATONIA; CATATONIC STUPOR; CONFUSION; DELIRIOUS MANIA; DEPRESSION; DEPRESSIVE PSYCHOSIS; DRUG HALF LIFE; EDITORIAL; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; GRAND MAL SEIZURE; HUMAN; LETHAL CATATONIA; MANIA; MEMORY DISORDER; MENTAL DISEASE; NEUROLEPTIC MALIGNANT SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOSIS; PUERPERAL PSYCHOSIS; RELAPSE; STUPOR; SUICIDAL BEHAVIOR; THERAPY EFFECT; TREATMENT INDICATION;

COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; MEMORY DISORDERS;

EID: 84856956948     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01812.x     Document Type: Editorial

References (64)

1. Goodman WK. Electroconvulsive therapy in the spotlight. N Engl J Med 2011;364:1785-1787.
2. Roueché B. As empty as Eve. New Yorker 1974;9:84-100.
3. Andre L. Doctors of deception. What they don't want you to know about shock treatment. New Brunswick/New Jersey/London: Rutgers University Press, 2009.
4. Fink M, Taylor MA. Electroconvulsive therapy. Evidence and challenges. JAMA 2007;208:330-332.
5. Lisanby S. Electroconvulsive therapy for depression. N Engl J Med 2007;357:1939-1945.
6. Petrides G, Fink M, Husain MM et al. ECT remission rates in psychotic versus non-psychotic depressed patients. A report from CORE. J ECT 2001;17:244-253.
7. Birkenhäger TK, Pluijms EM, Lucius SAP. ECT response in delusional versus nondelusional depressed inpatients. J Affect Disord 2003;74:191-195.
8. Avery D, Lubrano A. Depression treated with imipramine and ECT: the DeCarolis study reconsidered. Am J Psychiatry 1979;136:559-562.
9. Wijkstra J, Lijmer J, Balk F, Geddes J, Nolen WA Pharmacological treatment for psychotic depression. Cochrane Library 2009;1:1-46.
10. American Psychiatric Association. The practice of electroconvulsive therapy, recommendations for treatment, training and privileging. Washington DC: American Psychiatric Association, 2001.
11. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders. A systematic review and meta-analysis. Lancet 2003;361:799-808.
12. Kho KH, Van Vreeswijk MF, Simpson S, Zwinderman AH. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 2003;19:139-147.
13. Kellner CH, Fink M, Knapp R et al. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry 2005;162:977-982.
14. Sackeim HA, Haskett RF, Mulsant BH et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001;285:1299-1307.
15. Kellner CH, Knapp RG, Petrides G et al. Continuation electroconvulsive therapy vs. pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Arch Gen Psychiatry 2006;63:1337-1344.
16. Smith GE, Rasmussen KG, Collum CM et al. A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the consortium for research in ECT (CORE) study. J Clin Psychiatry 2010;71:185-193.
17. Imlah NW, Ryan E, Harrington JA. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. J Neuropsychopharmacol 1965;4:438-442.
18. Seager CP, Bird RL. Imipramine with electrical treatment in depression. A controlled trial. J Ment Sci 1962;108:704-707.
19. Lauritzen L, Odgaard K, Clemmesen L et al. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 1996;94:241-251.
20. Gagné GG Jr, Furman MJ, Carpenter LL, Price LH. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 2000;157:1960-1965.
21. Odeberg H, Rodriguez-Silva B, Salander P, Mårtensson B. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study. J ECT 2008;24:183-190.
22. Fraser LM, O'Carroll RE, Ebmeier KP. The effect of electroconvulsive therapy on autobiographical memory: a systematic review. J ECT 2008;24:10-17.
23. Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 2007;32:244-254.
24. Semkovska M, Mcloughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 2010;68:568-577.
25. Bergsholm P, Larsen JL, Rosendahl K, Holsten F. Electroconvulsive therapy and cerebral computed tomography. A prospective study. Acta Psychiatr Scand 1989;80:566-572.
26. Coffey CE, Weiner RD, Djang WT et al. Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. Arch Gen Psychiatry 1991;48:1013-1021.
27. Fink M. Complaints of the loss of personal memories after electroconvulsive therapy: evidence of a somatoform disorder? Psychosomatics 2007;48:290-293.
28. Cronholm B, Ottosson J-O. The experience of memory function after electroconvulsive therapy. Br J Psychiatry 1963;109:251-258.
29. Gibbons JL, Mchugh PR. Plasma cortisol in depressive illness. J Psychiatric Res 1962;1:162-171.
30. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-5043.
31. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000;157:115-117.
32. Nordanskog P, Dahlstrand U, Larsson MR, Larsson EM, Knutsson L, Johanson A. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study. J ECT 2010;26:62-67.
33. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingström A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 2000;47:1043-1049.
34. Jansson L, Wennström M, Johanson A, Tingström A. Glia cell activation in response to electroconvulsive seizures. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:1119-1128.
35. Hellsten J, Wennström M, Bengzon J, Mohapel P, Tingström A. Electroconvulsive seizures induce endothelial cell proliferation in adult rat hippocampus. Biol Psychiatry 2004;55:420-427.
36. Banasr M, Duman RS. Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviours. Biol Psychiatry 2008;64:863-870.
37. Bolwig TG. How does electroconvulsive therapy work? Theories on its mechanism Can J Psychiatry 2011;56:13-18.
38. Petersén A, Wörtwein G, Gruber SH, Mathé AA. Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model. Neurosci Lett 2008;436:305-308.
39. Petersén A, Wörtwein G, Gruber SH, El-Khoury A, Mathé AA. Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model. Neurosci Lett 2009;451:148-151.
40. Ottosson J-O. Experimental studies of the mode of action of electroconvulsive therapy. Acta Psychiatr Neurol Scand 1960;35(Suppl. 145):1-141.
41. D'Elia G. Unilateral electroconvulsive therapy. Acta Psychiatr Scand 1970;45(Suppl. 215):1-98.
42. Swartz CM. Efficiency of the stimulus characteristics of ECT. Am J Psychiatry 2000;157:1504-1506.
43. Swartz CM, Larson G. ECT stimulus duration and its efficacy. Ann Clin Psychiatry 1989;1:147-152.
44. Sand Strömgren L. Unilateral og bilateral ECT. Depression og hukommelse. Dissertation. Århus 1978.
45. Bergsholm P. Electroconvulsive therapy. Dissertation. Bergen 1995.
46. Swartz CM, Larson G. Generalization of the effects of unilateral and bilateral ECT. Am J Psychiatry 1986;143:1040-1041.
47. D'Elia G, Raotma H. Is unilateral ECT less effective than bilateral ECT? Br J Psychiatry 1975;126:83-89.
48. Ottosson J-O. Is unilateral nondominant ECT as efficient as bilateral ECT? A new look at the evidence Convuls Ther 1991;7:190-200.
49. Sackeim HA, Prudic J, Devanand DP et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000;57:425-434.
50. Kellner CH, Knapp R, Husain MM et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry 2010;196:226-234.
51. Swartz CM (ed.) Electroconvulsive and neuromodulation therapies. Cambridge: Cambridge University press, 2009.
52. Cronholm B, Ottosson J-O. Ultrabrief stimulus technique in electroconvulsive therapy. I. Influence on retrograde amnesia of treatments with the Elther ES electrochock apparatus, Siemens Konvulsator III and of lidocaine-modified treatment. J Nerv Ment Dis 1963;13:117-123.
53. Cronholm B, Ottosson J-O. Ultrabrief stimulus technique in electroconvulsive therapy. II. Comparative studies of therapeutic effects and memory disturbances in treatment of endogenous depression with the Elther ES electrochock apparatus, Siemens Konvulsator III and of lidocaine-modified treatment. J Nerv Ment Dis 1963;13:268-276.
54. Loo C, Sheehan P, Pigot M, Lyndon W. A report on mood and cognitive outcomes with right unilateral ultrabrief pulse width (0.3ms) ECT and retrospective comparison with standard pulse width right unilateral ECT. J Affect Disord 2007;103:277-281.
55. Mccormick LM, Brumm MC, Benede AK, Lewis JL. Relative ineffectiveness of ultrabrief right unilateral versus bilateral electroconvulsive therapy in depression. J ECT 2009;25:238-242.
56. Sackeim H, Prudic J, Nobler MS et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain stimul 2008;1:71-83.
57. Eranti SV, Mogg AJ, Pluck GC, Landau S, Mcloughlin DM. Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: a naturalistic comparison study. J Affect Disord 2009;113:165-171.
58. Greenberg RM, Pettinati HM. Benzodiazepines and electroconvulsive therapy. Convuls Ther 1993;9:262-273.
59. Jha AK, Stein GS, Fenwick P. Negative interaction between lithium and electroconvulsive therapy - a case-control study. Br J Psychiatry 1996;168:241-243.
60. Schou M. Lithium and electroconvulsive therapy: adversaries, competitors, allies? Acta Psychiatr Scand 1991;84:435-438.
61. D'Elia G, Lehmann J, Raotma H. Evaluation of the combination of tryptophan and ECT in the treatment of depression. 1. Clinical analysis. Acta Psychiatr Scand 1977;56:303-318.
62. D'Elia G, Lehmann J, Raotma H. Influence of tryptophan on memory functions in depressive patients treated with unilateral ECT. Acta Psychiatr Scand 1978;57:239-252.
63. Sackeim HA, Dillingham EM, Prudic J et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry 2009;66:729-737.
64. Ottosson J-O, Fink M. Ethics in electroconvulsive therapy. New York: Brunner-Routledge, 2004.